Cerebrovascular disease, APOE ε4 allele and cognitive decline in a cognitively normal population

Neurological Research

Volumn 28, Issue 6, 2006, Pages 650-656

  Qiu, Chengxuan ^a   Winblad, Bengt ^a   Fratiglioni, Laura ^a  

^a STOCKHOLM GERONTOLOGY RESEARCH CENTER   (Sweden)

Author keywords

APOE genotype; Cerebrovascular disease; Cognitive decline; Dementia; Population based study

Indexed keywords

APOLIPOPROTEIN E4;

AGED; ARTICLE; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DEMENTIA; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; POPULATION RESEARCH; SCORING SYSTEM;

AGED; AGED, 80 AND OVER; AGING; ALLELES; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CEREBROVASCULAR DISORDERS; COGNITION; COGNITION DISORDERS; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; RISK FACTORS;

EID: 33748947309     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164106X130443     Document Type: Article

References (29)

1. Qiu C, Fratiglioni L. Epidemiology of cerebrovascular disease related cognitive decline. Int Psychogeriatr 2003; 15 (Suppl. 1): 105-110
2. Leys D, Henon H, Mackowiak-Cordoliani MA, et al. Poststroke dementia. Lancet Neurol 2005; 4: 752-759
3. Kalmijn S, Feskens EJ, Launer LJ, et al. Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men. Stroke 1996; 27: 2230-2235
4. Dik MG, Deeg DJ, Bouter LM, et al. Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: A population-based study. Stroke 2000; 31: 2431-2436
5. Slooter AJ, Tang MX, van Dujin CM, et al. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. JAMA 1997; 277: 818-821
6. Zhu L, Fratiglioni L, Guo Z, et al. Incidence of dementia in relation to stroke and the apolipoprotein E epsilon4 allele in the very old: Findings from a population-based longitudinal study. Stroke 2000; 31: 53-60
7. Zhu L, Viitanen M, Guo Z, et al. Blood pressure reduction, cardiovascular diseases, and cognitive decline in the mini-mental state examination in a community population of normal very old people: A three-year follow-up. J Clin Epidemiol 1998; 51: 385-391
8. Fratiglioni L, Viitanen M, Bäckman L, et al. Occurrence of dementia in advanced age: The study design of the Kungsholmen project. Neuroepidemiology 1992; 11 (Suppl. 1): 29-36
9. Fratiglioni L, Viitanen M, von Strauss E, et al. Very old women at highest risk of dementia and Alzheimer's disease: Incidence data from the Kungsholmen Project, Stockholm. Neurology 1997; 48: 132-138
10. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, Washington, DC, WA: American Psychiatric Association, 1987
11. McKhann G, Drachmen D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Service Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944
12. Alfredsson L, von Arbin M, de Faire U. Mortality from and incidence of stroke in Stockholm. Br Med J (Clin Res Ed) 1986; 292: 1299-1303
13. Qiu C, Kivipelto M, Agüero-Torres H, et al. Risk and protective effects of APOE gene towards Alzheimer's disease in the Kungsholmen project: Variation by age and sex. J Neurol Neurosurg Psychiatry 2004; 75: 828-833
14. Xu WL, Qiu CX, Wahlin Å, et al. Diabetes mellitus and risk of dementia in the Kungsholmen project: A 6-year follow-up study. Neurology 2004; 63: 1181-1186
15. Qiu C, Winblad B, Marengoni A, et al. Heart failure and risk of dementia and Alzheimer disease: A population-based cohort study. Arch Intern Med 2006; 166: 1003-1008
16. Stampfer MJ, Kang JH, Chen J, et al. Effects of moderate alcohol consumption on cognitive function in women. N Engl J Med 2005; 352: 245-253
17. Zhu L, Fratiglioni L, Guo Z, et al. Association of stroke with dementia, cognitive impairment, and functional disability in the very old: A population-based study. Stroke 1998; 29: 2094-2099
18. Kang JH, Logroscino G, De Vivo I, et al. Apolipoprotein E, cardiovascular disease and cognitive function in aging women. Neurobiol Aging 2005; 26: 475-484
19. Haan MN, Shemahski L, Jagust WJ, et al. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 1999; 282: 40-46
20. Honig LS, Tang MX, Albert S, et al. Stroke and the risk of Alzheimer disease. Arch Neurol 2003; 60: 1707-1712
21. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215-1222
22. de la Torre JC. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 2004; 3: 184-190
23. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005; 4: 487-499
24. Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer disease: The Nun Study. JAMA 1997; 277: 813-817
25. Huang Y. Apolipoprotein E and Alzheimer disease. Neurology 2005; 66(Suppl. 1): 579-585
26. Winnock M, Letenneur L, Jacqmin-Gadda H, et al. Longitudinal analysis of the effect of apolipoprotein E epsilon4 and education on cognitive performance in elderly subjects: The PAQUID study. J Neurol Neurosurg Psychiatry 2002; 72: 794-797
27. Bretsky P, Guralnik JM, Launer L, et al. The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology 2003; 60: 1077-1081
28. Hsiung GY, Sadovnick AD, Feldman H. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: Data from the Canadian Study of Health and Aging. CMAJ 2004; 171: 863-867
29. Bunce D, Fratiglioni L, Small BJ, et al. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging. Neurology 2004; 63: 816-821